We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Singular Genomics Systems, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

43.76% less ownership

Funds ownership: 43.76% → 0% (-44%)

100% less funds holding

Funds holding: 20 → 0 (-20)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $21.5M → $0 (-$21.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
–
Holders Change
-20
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$7.23M
2
DM
Deerfield Management
New York
-$3.23M
3
UBS Group
UBS Group
Switzerland
-$3.04M
4
AVM
Arch Venture Management
Illinois
-$2.46M
5
QM
QVIDTVM Management
Texas
-$1.63M

OMIC Hedge Fund Activity: Q1 2025 in Review

0 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q1 2025, worth a combined $0 — down 100% from $21.5M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of OMIC and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $7.23M sold.

  • 0 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q1 2025, down from 20 in Q4 2024.
  • Funds reported $0 of Singular Genomics Systems, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q1 2025 and 20 closed out, a net change of -20 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q1 2025 was Tang Capital Management, an estimated $7.23M sold.

Based on aggregated 13F filings for Q1 2025.